Sarcoma  >>  Ayvakit (avapritinib)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ayvakit (avapritinib) / Blueprint Medicines
2020-005751-21: Clinical Trial Extension Study with Avapritinib for Patients with Gastrointestinal Stromal Tumors

Not yet recruiting
4
5
Europe
Avapritinib, BLU-285, Tablet
Blueprint Medicines, Blueprint Medicines
Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Tumours, Diseases [C] - Cancer [C04]
 
 
NCT04825574: Study for Patients Previously Treated in Avapritinib Clinical Trials

Active, not recruiting
4
5
Europe
Avapritinib, BLU-285
Blueprint Medicines Corporation
Gastrointestinal Stromal Tumors
08/25
08/25

Download Options